Related Experiment Video
Updated: Mar 16, 2026
Image-Guided Resection of Glioblastoma and Intracranial Implantation of Therapeutic Stem Cell-seeded Scaffolds
Published on: July 16, 2018
Infection-resistant MRI-visible scaffolds for tissue engineering applications
Morteza Mahmoudi1, Mingming Zhao2, Yuka Matsuura3
1Stanford Cardiovascular Institute, Stanford, CA, 94305 USA ; Division of Cardiovascular Medicine, Stanford University, 300 Pasteur Dr., Stanford, CA 94305 ; Nanotechnology Research Center and Department of Nanotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, 14155-6451, Iran.
This study engineered a collagen scaffold for tissue repair, making it visible with MRI and resistant to bacterial infection. This innovation enhances the safety and effectiveness of regenerative therapies.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Nanotechnology
Background:
- Tissue engineering relies on porous scaffolds for tissue regeneration.
- Clinical use of scaffolds is limited by infection risk and poor visibility in medical imaging.
- Previous work developed a type I collagen patch for myocardial repair.
Purpose of the Study:
- To create an MRI-visible and anti-infective tissue engineering scaffold.
- To enhance the clinical applicability of engineered collagen scaffolds.
Main Methods:
- Incorporation of superparamagnetic iron oxide nanoparticles into a bioengineered type I collagen patch.
- Evaluation of scaffold visibility using Magnetic Resonance Imaging (MRI).
- Assessment of antibacterial properties against Salmonella bacteria.
Main Results:
- The developed scaffold exhibited enhanced MRI visibility.
- The embedded nanoparticles demonstrated significant inhibition of Salmonella bacterial growth.
- The modified scaffold maintained its tissue engineering potential.
Conclusions:
- Superparamagnetic iron oxide nanoparticles can confer both MRI-visibility and anti-infective properties to collagen scaffolds.
- These enhanced scaffolds hold promise for improving clinical outcomes in regenerative therapies.
- This approach addresses key limitations in current biomaterial-based treatments.
